Repository logo
  • English
  • 中文
Log In
Have you forgotten your password?
  1. Home
  2. College of Medicine / 醫學院
  3. Clinical Medicine / 臨床醫學研究所
  4. Hbeag-Negative Chronic Hepatitis B: Cost-Effectiveness of Peginterferon Alfa-2a Compared to Lamivudine in Taiwan
 
  • Details

Hbeag-Negative Chronic Hepatitis B: Cost-Effectiveness of Peginterferon Alfa-2a Compared to Lamivudine in Taiwan

Resource
VALUE IN HEALTH v.11 n.2 pp.131-138
Journal
Value in Health
Pages
131-138
Date Issued
2008
Date
2008
Author(s)
Veenstra, David L.
Sullivan, Sean D.
Lai, Ming-Yang
Lee, Chuan-Mo
Tsai, Chia-Ming
Patel, Kavita K.
DOI
10.1111/j.1524-4733.2007.00221.x
URI
http://ntur.lib.ntu.edu.tw//handle/246246/175429
Abstract
Objective: In Taiwan, the carrier rate of hepatitis B surface antigen is 15% to 20%, one of the highest in the world. Among chronic hepatitis B ( CHB) patients, hepatitis B e antigen (HBeAg)-negative accounts for approximately 40% to 50% of these patients. A recent study found that peginterferon alfa-2a (40 KD) is more effective than lamivudine in treating HBeAg-negative CHB, but its cost- effectiveness has not been evaluated. Our objective is to evaluate the incremental cost-effectiveness of 48 weeks of peginterferon alfa-2a compared to 48 weeks of lamivudine, from the perspective of the Taiwan Bureau of National Health Insurance. Methods: A Markov model was used to simulate the natural history of HBeAg- negative CHB in a cohort of 40- year-old patients. Efficacy, disease progression, economic, and quality-of-life data were derived from published literature and a survey of clinical experts in Taiwan. Life expectancy, quality-adjusted life expectancy, lifetime costs in New Taiwan Dollars (NTD) (1 USD = 31.96 NTD), and incremental cost-effectiveness ratios (ICERs) were calculated. Results: The gain in quality-adjusted life -years (QALYs) for 48 weeks of peginterferon alfa-2a compared to 48 weeks of lamivudine was 0.45 at an additional cost of 157, 000 NTD (4900 USD), resulting in an ICER of 347,000 NTD (10, 900 USD) per QALY gained. The 95% central range for the ICER from a probabilistic sensitivity analysis was 228,000- 566, 000 NTD (7100-17,700 USD). Conclusions: In HBeAg- negative CHB, 48 weeks of treatment with peginterferon alfa- 2a compared to 48 weeks of lamivudine appears to offer life expectancy and quality-of-life improvements at an acceptable cost-effectiveness ratio.
Subjects
cost-effectiveness
hepatitis B
lamivudine
peginterferon
Taiwan
SDGs

[SDGs]SDG3

Other Subjects
hepatitis B(e) antigen; lamivudine; peginterferon alpha2a; article; billing and claims; clinical trial; controlled clinical trial; controlled study; cost effectiveness analysis; decompensated liver cirrhosis; disease course; drug cost; drug efficacy; health care cost; health survey; hepatitis B; human; life expectancy; liver cell carcinoma; liver transplantation; medical literature; monotherapy; priority journal; quality adjusted life year; quality of life; randomized controlled trial; sensitivity analysis; socioeconomics; Taiwan; treatment response

臺大位居世界頂尖大學之列,為永久珍藏及向國際展現本校豐碩的研究成果及學術能量,圖書館整合機構典藏(NTUR)與學術庫(AH)不同功能平台,成為臺大學術典藏NTU scholars。期能整合研究能量、促進交流合作、保存學術產出、推廣研究成果。

To permanently archive and promote researcher profiles and scholarly works, Library integrates the services of “NTU Repository” with “Academic Hub” to form NTU Scholars.

總館學科館員 (Main Library)
醫學圖書館學科館員 (Medical Library)
社會科學院辜振甫紀念圖書館學科館員 (Social Sciences Library)

開放取用是從使用者角度提升資訊取用性的社會運動,應用在學術研究上是透過將研究著作公開供使用者自由取閱,以促進學術傳播及因應期刊訂購費用逐年攀升。同時可加速研究發展、提升研究影響力,NTU Scholars即為本校的開放取用典藏(OA Archive)平台。(點選深入了解OA)

  • 請確認所上傳的全文是原創的內容,若該文件包含部分內容的版權非匯入者所有,或由第三方贊助與合作完成,請確認該版權所有者及第三方同意提供此授權。
    Please represent that the submission is your original work, and that you have the right to grant the rights to upload.
  • 若欲上傳已出版的全文電子檔,可使用Open policy finder網站查詢,以確認出版單位之版權政策。
    Please use Open policy finder to find a summary of permissions that are normally given as part of each publisher's copyright transfer agreement.
  • 網站簡介 (Quickstart Guide)
  • 使用手冊 (Instruction Manual)
  • 線上預約服務 (Booking Service)
  • 方案一:臺灣大學計算機中心帳號登入
    (With C&INC Email Account)
  • 方案二:ORCID帳號登入 (With ORCID)
  • 方案一:定期更新ORCID者,以ID匯入 (Search for identifier (ORCID))
  • 方案二:自行建檔 (Default mode Submission)
  • 方案三:學科館員協助匯入 (Email worklist to subject librarians)

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science